Immunotherapy of metastatic disease

J. E. Talmadge, P. L. Black

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


It appears that the cytokines have significant therapeutic potential as an adjunct to established therapeutic regimens. It appears that, as single agents, they will have minimal therapeutic activity. However, in minimal residual disease settings or after debulking regimens by surgery, chemotherapy, or radiotherapy, significantly increased therapeutic activity can be expected by the addition of cytokines to treatment protocols.

Original languageEnglish (US)
Pages (from-to)79-87
Number of pages9
JournalSeminars in Thrombosis and Hemostasis
Issue number1
StatePublished - 1988
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Immunotherapy of metastatic disease'. Together they form a unique fingerprint.

Cite this